Article
Safety and Efficacy of Direct-acting Antiviral Therapies for Chronic HCV Infection in Hemodialysis Patients.
In vivo (Athens, Greece) - 1 Jan 2000
Droc Gabriela, Istrate Mircea, Mercan-Stanciu Adriana, Dodot Mihai, Isac Teodora, Toma Letitia, Zgura Anca, Trifan Anca, Serbanica Andreea Nicoleta, Iliescu Laura, Micu Laurentiu
Abstract excerpt
BACKGROUND/AIM: The aim of this study was to determine the safety and efficacy of a direct-acting antiviral treatment, ombitasvir/paritaprevir/ritonavir and dasabuvir, without ribavirin, in a real-life setting. PATIENTS AND METHODS: We performed a prospective observational study including 108 patients undergoing hemodialysis for end-stage kidney disease, referred to our clinic for antiviral therapy for chronic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.